A synthetic peptide for use as a blocking control in assays to test for specificity of HADH antibody, Alternative Names: HADH control peptide, HADH antibody Blocking Peptide, Anti-HADH Blocking Peptide, Hydroxyacyl-Coenzyme A Dehydrogenase Blocking Peptide, HAD Blocking Peptide, HADH1 Blocking Peptide, HADHSC Blocking Peptide, HHF4 Blocking Peptide, M/SCHAD Blocking Peptide, MGC8392 Blocking Peptide, SCHAD Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
HADH
(Hydroxyacyl-CoA Dehydrogenase (HADH))
Hintergrund
HADH functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene.